Journal article icon

Journal article

Evolving management of patients treated by drug-eluting stent: Prevention of late events

Abstract:

Summary: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared with BMS. However, this benefit is mainly evident in the first year of follow-up. Indeed, DES-related events may extend over this time, due to late events (late ISR and/or very late stent thrombos...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Publisher:
Elsevier Inc.
Journal:
Cardiovascular Revascularization Medicine
Volume:
15
Issue:
2
Pages:
100-108
Publication date:
2014-01-01
DOI:
EISSN:
1878-0938
ISSN:
1553-8389
URN:
uuid:111fa77e-ed51-419d-a8d3-2f85be5877f9
Source identifiers:
460200
Local pid:
pubs:460200

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP